Braun Stacey Associates’s Amgen AMGN Stock Holding History

Braun Stacey Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Hold	4,500	–	–	0.05%	95
2026 Q1	$1.58M	Sell	4,500 -300	-6%	-$107K	0.05%	93
2025 Q4	$1.57M	Buy	4,800 +300	+7%	+$95.2K	0.05%	93
2025 Q3	$1.27M	Sell	4,500 -34,949	-89%	-$10.1M	0.04%	95
2025 Q2	$11M	Sell	39,449 -2,304	-6%	-$653K	0.4%	85
2025 Q1	$13M	Sell	41,753 -141	-0.3%	-$41.6K	0.53%	72
2024 Q4	$10.9M	Sell	41,894 -12,283	-23%	-$3.64M	0.41%	82
2024 Q3	$17.5M	Buy	54,177 +1,561	+3%	+$511K	0.66%	66
2024 Q2	$16.4M	Sell	52,616 -2,069	-4%	-$608K	0.64%	70
2024 Q1	$15.5M	Buy	54,685 +9,220	+20%	+$2.7M	0.62%	75
2023 Q4	$13.1M	Buy	+45,465	New	+$12.4M	0.59%	74
2022 Q4	–	Sell	-2,700	Closed	-$609K	–	117
2022 Q3	$609K	Sell	2,700 -200	-7%	-$48.5K	0.04%	111
2022 Q2	$706K	Buy	+2,900	New	+$711K	0.04%	114
2019 Q2	–	Sell	-10,664	Closed	-$2.03M	–	116
2019 Q1	$2.03M	Buy	10,664 +901	+9%	+$172K	0.13%	104
2018 Q4	$1.9M	Buy	+9,763	New	+$1.9M	0.15%	104

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Braun Stacey Associates's AMGN Position: Q2 2026 in Review

Braun Stacey Associates held its Amgen (AMGN) position steady in Q2 2026 at 4,500 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #95.

Braun Stacey Associates first reported a position in AMGN in Q4 2018 and has held it in 15 quarters since. The position peaked at $17.5M in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Braun Stacey Associates held 4,500 shares of Amgen worth $1.63M as of Q2 2026.
Braun Stacey Associates left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.05% of Braun Stacey Associates's portfolio in Q2 2026, its #95 holding.
Braun Stacey Associates first reported a position in Amgen in Q4 2018 and has held it in 15 quarters since.
Braun Stacey Associates's Amgen position peaked at $17.5M in Q3 2024.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Braun Stacey Associates's 13F filing for Q2 2026, filed 5 Aug 2026.